Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to < 6 Years

CONCLUSION: These data contribute to the understanding of the long-term safety of an extended-release stimulant in children 4 to < 6 years of age. The observed risk of a TEAE-related discontinuation was ∼11%. TEAEs were not dose-related and most were of mild to moderate severity. Symptom control was maintained through the year-long study.

via https://pubmed.ncbi.nlm.nih.gov/33892111/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20210508011003&v=2.14.4